Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated “Human Immune System” Mice
Open Access
- 4 October 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (10) , e13137
Abstract
Passive transfer of antibodies not only provides immediate short-term protection against disease, but also can be exploited as a therapeutic tool. However, the ‘humanization’ of murine monoclonal antibodies (mAbs) is a time-consuming and expensive process that has the inherent drawback of potentially altering antigenic specificity and/or affinity. The immortalization of human B cells represents an alternative for obtaining human mAbs, but relies on the availability of biological samples from vaccinated individuals or convalescent patients. In this work we describe a novel approach to generate fully human mAbs by combining a humanized mouse model with a new B cell immortalization technique. After transplantation with CD34+CD38− human hematopoietic progenitor cells, BALB/c Rag2−/−IL-2Rγc−/− mice acquire a human immune system and harbor B cells with a diverse IgM repertoire. “Human Immune System” mice were then immunized with two commercial vaccine antigens, tetanus toxoid and hepatitis B surface antigen. Sorted human CD19+CD27+ B cells were retrovirally transduced with the human B cell lymphoma (BCL)-6 and BCL-XL genes, and subsequently cultured in the presence of CD40-ligand and IL-21. This procedure allows generating stable B cell receptor-positive B cells that secrete immunoglobulins. We recovered stable B cell clones that produced IgM specific for tetanus toxoid and the hepatitis B surface antigen, respectively. This work provides the proof-of-concept for the usefulness of this novel method based on the immunization of humanized mice for the rapid generation of human mAbs against a wide range of antigens.Keywords
This publication has 45 references indexed in Scilit:
- Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnullhumanized miceProceedings of the National Academy of Sciences, 2010
- Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programmingNature Medicine, 2009
- Priming of protective T cell responses against virus-induced tumors in mice with human immune system componentsJournal of Experimental Medicine, 2009
- IL-15 trans-presentation promotes human NK cell development and differentiation in vivoJournal of Experimental Medicine, 2008
- T cell–independent development and induction of somatic hypermutation in human IgM+IgD+CD27+ B cellsJournal of Experimental Medicine, 2008
- Rapid cloning of high-affinity human monoclonal antibodies against influenza virusNature, 2008
- Antigen-specific human T-cell responses and T cell–dependent production of human antibodies in a humanized mouse modelBlood, 2008
- Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1Journal of Experimental Medicine, 2007
- Disseminated and sustained HIV infection in CD34+cord blood cell-transplanted Rag2−/−γc−/−miceProceedings of the National Academy of Sciences, 2006
- An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirusNature Medicine, 2004